Martin Rabel, Dipl.-Pharm., Ph.D. currently works as a Global Sales Specialist | Biopharma Services for Cytiva supporting clients in Europe, Middle East, and Africa (EMEA) and Asia & Pacific (APAC). He obtained his pharmaceutical license as well as a postgraduate diploma from the Friedrich-Schiller-University Jena working on Bacterial Nanocellulose (BNC) nanoparticles for gene delivery applications. His Ph.D. research focused on the development of animal-free simulation models for the development of complex diagnostic nanoparticles (IONP) and other nanomedicines as well as nanoparticle characterization and manufacturing methods. He joined Precision NanoSystems ULC in 2019 as Field Application Scientist. He is specialized in the development of novel nanomedicines using PNI´s microfluidic NanoAssemblr platform and gene delivery reagents and solutions. His expertise spans formulation development, optimization as well as scale-up including GMP manufacturing